On October 1, 2015, an order regarding the motion for authority to sell assets of the estates pursuant to section 363 of the Bankruptcy Code was filed in the bankruptcy case of Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) and its affiliates.
The filing was assigned docket number 186 and is described on the court’s official docket as follows:
Order (WITH REVISIONS BY THE COURT) (A) Approving The Sale Of Substantially All Of The Debtor’s Assets, And (B) Approving The Assumption And Assignment Of Certain Executory Contracts And Unexpired Leases. (Related Doc # ) Order Signed on 10/1/2015. (BJM)
Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on August 9, 2015. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 15-11663. The bankruptcy case is currently assigned to United States Bankruptcy Judge Laurie Selber Silverstein. The law firm of Pachulski Stang Ziehl & Jones LLP is acting as lead bankruptcy counsel to Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) in the bankruptcy case.